baber/WOPTO huggingface dataset:
Patent JP-2023543461-A (JP)
Title: インターロイキン－１８結合タンパク質と血清アルブミンに対する抗原結合断片とを含む組換え融合タンパク質ならびにその組成物および使用
IPC: C12N15/62
Filed: 2021-09-29
Abstract: インターロイキン-18結合タンパク質と血清アルブミンに対する抗原結合断片とを含む組換え融合タンパク質、ならびにその使用を提供する。この組換え融合タンパク質は、体内での半減期の増加による改善された投与サイクルを有する。さらに、組換え融合タンパク質は、低い免疫原性を有し、生体内で副作用を引き起こさず、したがって、様々な癌および免疫疾患および状態の処置に有効に用いることができる。
Patent JP-2023544822-A (JP)
Title: Ｉ型ｃｒｉｓｐｒ関連トランスポザーゼシステム
IPC: C12N15/09
Filed: 2021-10-08
Abstract: 標的遺伝子修飾、標的挿入、遺伝子転写産物の摂動、及び核酸編集のためのシステム及び方法。新規の核酸標的化システムは、１つ以上のトランスポザーゼの構成要素と、ＣＲＩＳＰＲ－Ｃａｓシステムの１つ以上の構成要素と、転位性エレメントとを含むことができる。【選択図】図１
Patent JP-2023545773-A (JP)
Title: エアロゾル発生ロッドの製造の際の半径方向外側からの添加物の適用
IPC: A24C5/01
Filed: 2021-10-08
Abstract: エアロゾル発生ロッドを製造するための装置は、合流装置と、サセプタガイドと、コンベアシステムとを備える。合流装置は、軸方向に沿って合流する形成空間を有する。サセプタガイドは、合流装置形成空間の中に延び、かつ合流装置の形成空間内のサセプタ用の出口開口部を備える。コンベアシステムは、サセプタを組み込むロッドへと充填材料を成形するために、充填材料、好ましくはシートとして形成された充填材料を、合流装置の形成空間を通して搬送するように構成されている。装置は、サセプタガイドの半径方向外側に合流装置の形成空間の中に開口する分注開口部を有する少なくとも一つの添加物供給ラインをさらに備える。【選択図】図１
Patent JP-2023549311-A (JP)
Title: 無－基材タイプのディスプレイ装置用カバーウィンドウ、これを含むディスプレイ装置およびその製造方法
IPC: C08G59/30
Filed: 2022-10-07
Abstract: 【要約】本発明は、基材フィルムがなくても、柔軟性および高硬度の物性バランスを同時に満足するように実現しながら、特に繰り返しの曲げや折り畳み動作によってもフィルムの損傷がほとんどなく、ベンダブル、フレキシブル、ローラブル、またはフォルダブルモバイル機器、またはディスプレイ機器などに容易に適用可能な無－基材（ｓｕｂｓｔｒａｔｅ ｌｅｓｓ）タイプのディスプレイ装置のカバーウィンドウおよびこれを含むディスプレイ装置に関する。
Patent JP-2024500612-A (JP)
Title: 情報の送信と暗号鍵の配送とのための光通信のための方法、ならびにその方法を実装するためのシステム
IPC: H04B10/70
Filed: 2021-11-30
Abstract: 本発明は、特定の光搬送波波長のレーザー・ビームが、情報ビットと暗号鍵ビットとを同時に符号化する変調シンボルの共通セットによって変調され、シンボルは、光強度と時間遅延とを含むグループから選択される少なくとも１つのパラメータが異なり、異なる鍵ビットを符号化するために使用されるシンボルは光強度が異なることを特徴とする、送信機においてレーザー・ビーム強度変調を使用し、受信機において直接検出を使用して情報ビットの同時送信と暗号鍵ビットの配送とを伴う光通信のための方法を包含する。本発明はまた、上述の方法を実装するためのシステムを提示する。【選択図】図１
Patent JP-2023551516-A (JP)
Title: クローズドセル層を有するシート
IPC: B32B3/26
Filed: 2021-11-29
Abstract: 本発明は、クローズドセル層を有するシートに関するものであり、具体的には、環境に優しい樹脂フィルム上に形成された複数のクローズドセルと、所定のイメージが印刷された印刷部とを含む環境に優しいシートを提供する。本発明に係るシートは、外部からの衝突や厳しい外部環境の条件下でも変形や破損などが防止され、クローズドセルの形態保持性、クローズドセルの弾性保持、及びシートの形態耐久性を向上させ得るとともに、特定のイメージを印刷することで識別力を有することができ、環境にやさしいという利点を有する。【選択図】図１
Patent JP-2023553001-A (JP)
Title: マスタノードおよびセカンダリノードによるユーザ機器コネクティビティを管理するための方法およびデバイス
IPC: H04W76/27
Filed: 2021-12-06
Abstract: ネットワークノードは、ユーザ機器(UE)に対するマスタノード(MN)として動作し、ユーザ機器はMNおよびセカンダリノード(SN)とデュアルコネクティビティ(DC)で通信する。セカンダリセルグループ(SCG)の非アクティブ化を管理するために、ネットワークノードは、SCGが非アクティブ化されたことを決定し(2202)、SCGが非アクティブ化されたときにMNとUEとの間の無線接続がサスペンドされるべきであることを決定し(2206)、無線接続をサスペンドする(2208)。
Patent JP-2023554024-A (JP)
Title: モデル及び肺動脈自己移植片のモデリング方法
IPC: A61F2/06
Filed: 2021-12-15
Abstract: イメージスキャナ（８）を用いて、患者の心臓に取り付けられる有望な肺動脈自己移植片用の外部支持体をモデリングする方法であって：スキャナ（８）を用いて、心臓の収縮期中に、心臓の血管系の少なくとも１つのスキャンを取得するステップ（１００）；処理装置（２）を用いて、各スキャンを処理して有望な肺動脈自己移植片のモデルを構築するステップ（１０２）；及び、有望な肺動脈自己移植片のモデルを処理して、外部支持体のモデルを生成するステップ（１０４）を含む方法が提供されている。【選択図】図２
Patent JP-2023554112-A (JP)
Title: 熱安定性に優れたアルロースエピマー化酵素変異体、その製造方法およびこれを用いたアルロースの製造方法
IPC: C12N15/61
Filed: 2021-11-22
Abstract: 本発明は、フラボニフラクター・プラウティ（Ｆｌａｖｏｎｉｆｒａｃｔｏｒ ｐｌａｕｔｉｉ）に由来する野生型Ｄ－アルロース３－エピマー化酵素のアミノ酸配列のうち、特定の位置に存在するアミノ酸残基が他のアミノ酸残基に置換された新規なアルロースエピマー化酵素変異体およびその多様な用途が提供される。本発明による新規なアルロースエピマー化酵素変異体は、フラボニフラクター・プラウティ（Ｆｌａｖｏｎｉｆｒａｃｔｏｒ ｐｌａｕｔｉｉ）に由来する野生型Ｄ－アルロース３－エピマー化酵素またはＤ－アルロースエピマー化酵素変異体Ｗ２９Ｋ／Ｇ２１６Ｓ／Ｍ２３４Ｉに比べて果糖のアルロースへの転換活性が高く、特に６０℃以上の高温条件で熱安定性が非常に優れるため、アルロースの大量生産のための産業化レベルの酵素転換反応時の汚染を防止することができ、生産時間を短縮することができ、生産コストを節約することができる。
Patent JP-2024502274-A (JP)
Title: 物理気相堆積によるフォトレジスト
IPC: C23C14/34
Filed: 2021-11-18
Abstract: 実施形態には、基板上に金属オキソフォトレジストを形成する方法が含まれる。一実施形態において、本方法は、真空チャンバ内にターゲットを提供することを含み、ターゲットは金属を含む。続いて、本方法は、炭化水素ガスと不活性ガスを真空チャンバ内に流し、真空チャンバ内でプラズマを発生させることができる。一実施形態において、さらに続いて、本方法は、基板上に金属オキソフォトレジストを堆積させ、金属オキソフォトレジストは、金属－炭素結合および金属－酸素結合を含む。【選択図】図１
Patent JP-2024502664-A (JP)
Title: ビデオ生成方法、装置、電子機器および記憶媒体
IPC: H04N21/854
Filed: 2022-01-10
Abstract: 本開示は、ビデオ生成方法、装置、電子機器および記憶媒体を開示する。ビデオ生成方法は、目標音楽を用いてビデオを生成する第１トリガ操作を受信することと（Ｓ１０１）、第１トリガ操作に応答して、目標音楽の第１音楽特徴情報に基づき、自ユーザの候補素材セットから目標音楽に合致する候補素材を選択して目標候補素材とし、目標候補素材に従い、目標音楽をバックグラウンドミュージックとする目標ビデオを生成することと（Ｓ１０２）を含む。【選択図】図１
Patent MX-2007004794-A (MX)
Title: Thienopyridines as allosteric potentiators of the m4 muscarinic receptor.
Inventor: ESTEBAN ALMUDENA RUBIO
IPC: C07D495/04
Filed: 2005-10-18
Abstract: The present invention relates to selective allosteric potentiators of the Formula (I): or pharmaceutically acceptable salts thereof, for the treatment of disorders associated with M4 muscarinic receptors.
Patent MX-2007006206-A (MX)
Title: A combination of n-(3-metoxy-5-methylpyrazin-2-yl)-2-(4-`1,3,4- oxadiazol-2-yl!phenyl)pyridine-3-sulphonamide and an anti- mitotic agent for the treatment of cancer.
Inventor: BOYLE FRANCIS THOMAS
IPC: A61K31/497
Filed: 2005-11-23
Abstract: A combination, comprising N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl] phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent.
Patent MX-2007008293-A (MX)
Title: Controlled release compositions for interferon based on pegt/pbt block copolymers.
Inventor: BECHET ANNE CHANTAL
IPC: A61K9/113
Filed: 2006-01-06
Abstract: The invention discloses a pharmaceutical composition for the controlled release of relatively toxic active compounds, in particular for bioactive proteins from the class of interferons. The composition comprises a biodegradable block copolymer constructed from poly(ethylene glycol) terephthalate (PEGT) and poly(butylene terephthalate) (PBT). The composition is provided in the form of injectable microparticles, of an in-jectable liquid which may have self-gelling properties, or of a solid implant. The inven-tion further provides a pharmaceutical kit comprising the composition, methods for pre-paring the composition, and the pharmaceutical uses relating thereto.
Patent MX-2007009514-A (MX)
Title: Method of making 1,1,1-trifluoroethane.
Inventor: MARKEL DANIEL C
IPC: C07C17/21
Filed: 2006-02-01
Abstract: A process for producing 1,1,1-trifluoroethane (HFC- 143a) which process comprises reacting hydrogen fluoride with vinylidene chloride along with one or more of 1,1,-dichloro-l-fluoroethane (HCFC-141b), l-chloro-l,l-difluoroethane (HCFC-142b) and 1,1,1-trichloroethane (HCC-140a) in the presence of pentavalent antimony as a fluorination catalyst under conditions to produce 1,1,1-trifluoroethane (HFC- 143a), generally in yields of 90% or more.
Patent MX-2007011066-A (MX)
Title: Power supply for underground and pad mounted power distribution systems.
Inventor: LINDSEY KEITH E
IPC: H02J7/00
Filed: 2006-03-10
Abstract: A power supply generated through a set of current transformers is disclosed. The current transformers may be removably attached to a primary power line such as a high voltage power line. The power supply may be used to power a device or charge a battery for a device that requires a low voltage input. The power supply may be used in underground vaults and pad mounted chambers that contain high voltage power lines. The power supply may generate a low voltage direct current out put that is not available in the vicinity of high voltage power lines in an underground vault or pad mounted chamber.
Patent MX-2007013031-A (MX)
Title: Toxin peptide therapeutic agents.
Inventor: HU SHAW-FEN SYLVIA
IPC: C12N15/12
Filed: 2006-04-18
Abstract: Disclosed is a composition of matter of the formula (I) (X<sup>1</sup>)<sub>a</sub>-(F<sup>1</sup>)<sub>d</sub>-(X<sup> 2</sup>)<sub>b</sub>-(F<sup>2</sup>)<sub>e</sub>-(X<sup>3</sup>) <sub>c</sub> and multimers thereof, in which F1 and F2 are half-life extending moieties, and d and e are each independently 0 or 1, provided that at least one of d and e is 1; X<sup>1</sup>, X<sup>2</sup>, and X<sup>3</sup> are each independently -(L)<sub>f</sub>-P-(L)<sub>g</sub>-, and f and g are each independently 0 or 1; P is a toxin peptide of no more than about 80 amino acid residues in length, comprising at least two intrapeptide disulfide bonds; L is an optional linker; and a, b, and c are each independently 0 or 1, provided that at least one of a, b and c is 1. Linkage to the half-life extending moiety or moieties increases the in vivo half-life of the toxin peptide, which otherwise would be quickly degraded. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are a DNA encoding the inventive composition of matter, an expression vector comprising the DNA, and a host cell comprising the expression vector. Methods of treating an autoimmune disorder, such as, but not limited to, multiple sclerosis, type 1 diabetes, obesity, psoriasis, inflammatory bowel disease, contact-mediated dermatitis, rheumatoid arthritis, psoriatic arthritis, transplant rejection, graft-versus-host disease, and lupus and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.
Patent MX-2007015380-A (MX)
Title: Method and device for extracting a metal from a slag containing the metal.
Inventor: KUNZE JURGEN
IPC: C22B15/00
Filed: 2006-06-08
Abstract: The invention concerns a method for extracting a metal from a slag containing the metal, in which the liquefied metal-containing slag is heated in at least one arc furnace (1, 2). In order to develop an improved method for extracting, in particular, copper from slag, the invention provides for the metal-containing slag to be heated in a first furnace (1) in the form of an AC or DC electric furnace and for the melt from the first furnace (1) to be transferred to a second furnace (2) in the form of a DC electric furnace. The invention also concerns a device for extracting a metal from a slag containing the metal.
Patent MX-2007015829-A (MX)
Title: Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1.
Inventor: RITTER KURT
IPC: A61K31/4162
Filed: 2006-06-13
Abstract: The invention relates to 6-amido substituted pyrazolopyridine derivatives of the formula (I) useful as inhibitors of beta-adrenergic receptor kinase 1 (??ARK-1 ), compositions containing such-compounds and their use for the treatment and prevention of chronic heart failure, hypertension, myocardial ischemia and hepatitis C virus (HCV) infections, and for the prevention of opiate addiction.
Patent MX-2007016144-A (MX)
Title: Heteroaryl derivatives for treating viruses.
Inventor: ROBERTS CHRISTOPHER DON
IPC: C07D401/04
Filed: 2006-06-22
Abstract: Disclosed are compounds, compositions, and methods for treating Flaviviridae family virus infections.
Patent MX-2007016569-A (MX)
Title: Poly-antigenic vaccine for the prevention and control of mastitis in bovine cattle.
Inventor: CORDOVA JOSE DE JESUS RAMIREZ
IPC: C12N1/00
Filed: 2007-12-19
Abstract: The present invention refers to the production of a poly-antigen vaccine for preventing and controlling bovine cattle caused by Staphylococcus aureus and Escherichia coli. The inventive vaccine is characterised in that it includes wild Mexican isolates of S. Aureus. The vaccine includes killed whole-cells from three strains of S. Aureus. Moreover, the vaccine is produced with exotoxins resulting from a fourth strain of S. Aureus. The vaccine is additionally combined with killed cells from the strain J5 of E. Coli obtained from the collection of the ATCC (American Type Culture Collection, EEUU) in order to increase the protection spectrum. Finally, the vaccine includes in the formulation thereof an oily adjuvant comprising peanut oil developed by the inventors, which promotes the retention of antigens in the site of administration and provokes the immune response to increase. The invention also includes a method for stimulating the immune system of animal against the antigens of the se lected strains of S. aureus by means of the administration of a vaccine prepared according to the present invention.
Patent MX-2008000895-A (MX)
Title: Heterogeneous supported catalytic carbamate process.
Inventor: MOLZAHN DAVID C
IPC: C07C269/04
Filed: 2006-07-17
Abstract: A process for the preparation of aromatic carbamates comprising contacting one or more organic carbonates with an aromatic amine or urea in the presence of a catalyst and recovering the resulting aromatic carbamate product, characterized in that the catalyst is a heterogeneous catalyst comprising a Group 12-15 metal compound supported on a substrate.
Patent MX-2008001178-A (MX)
Title: Autonomic nerve stimulation to treat a gastrointestinal disorder.
Inventor: MASCHINO STEVEN E
IPC: A61N1/36
Filed: 2006-06-26
Abstract: <p num="0000"/>.
Patent MX-2008001261-A (MX)
Title: Scf extract containing cardiac glycoside.
Inventor: ADDINGTON CRANDELL
IPC: A61K36/185
Filed: 2006-07-26
Abstract: A supercritical fluid (SCF) extract of a cardiac glycoside-containing plant mass is provided. The extract can be included in a pharmaceutical composition containing an extract-solubilizing amount of solubilizer. Oleandrin is included within the extract when a cardiac glycoside-containing plant, such as Nerium oleander, is extracted by SCF extraction. The extract can also contain one or more other SCF extractable pharmacologically active agents. The composition can be used to treat a wide range of disorders that are therapeutically responsive to a cardiac glycoside.
Patent MX-2008003222-A (MX)
Title: Cationic polymer latex.
Inventor: CREAMER MARIANNE PATRICIA
IPC: C08L21/02
Filed: 2008-03-07
Abstract: There is provided an aqueous liquid domestic composition comprising (i) one or more active component selected from the group consisting of (A) 3% to 50% by weight, based on the total solids weight of said domestic composition, one or more softening agent, (B) 2% to 90% by weight, based on the total solids weight of said domestic composition, one or more anionic surfactant, and (C) a mixture consisting of (I) 1% to 25% by weight, based on the total solids weight of said domestic composition, one or more softening agent, and (II) 5% to 75% by weight, based on the total solids weight of said domestic composition, one or more anionic surfactant, and (D) 0.1 %to 30% by weight, based on the total solids weight of said domestic composition, one or more amphoteric compound; ; and(ii) one or more cationic polymer latex comprising (I) 0.5% to 6% by weight, based on the dry weight of said polymer, one or more cationic monomer, (II) 30% to 99.5 by weight, based on the dry weight of said polymer, polymerized units of one or more aromatic monomer, (III) optionally, polymerized units of one or more additional monomer. Also provided is a method of treating paper with such cationic polymer latices.
Patent MX-2008008128-A (MX)
Title: Residual fuel oil additive.
Inventor: JORDAN FREDERICK L
IPC: C10L1/00
Filed: 2006-12-21
Abstract: Fuel additives are disclosed for high-asphaltene carbonaceous fuels such as residual fuel oil or coal. Such additives provide improved combustion characteristics. Such improved combustion characteristics include one or both of improved efficiency and decreased emissions of pollutants. In particular, the fuel additives include an extract from a plant such as fescue, alfeque, or alfalfa, and optionally, an organometallic compound. The use of a fuel additive including both a plant extract and an organometallic compound is particularly useful in improving the combustion characteristics of fuels with particularly high asphaltene content.
Patent MX-2008014396-A (MX)
Title: Device and method for repairing structural components.
Inventor: WHITWORTH DENVER
IPC: B23K31/02
Filed: 2006-05-11
Abstract: A device for repairing a structural component (305) having a first member (401 ) adapted for bonding to a structural component (305).
Patent MX-2009004312-A (MX)
Title: Preform for the production of biaxially extended plastic bottles, and plastic bottle produced from a preform.
Inventor: SIEGEL ROBERT M
IPC: B29C49/06
Filed: 2007-10-05
Abstract: A preform (1) for the production of biaxially extended plastic bottles has a rigid, substantially elongated body (2), which at one longitudinal end thereof comprises a base (3) and the opposite longitudinal end of which is configured as a neck section (4) provided with a pouring opening (5). The preform (1) has outer and inner walls (A, I), which extend at least across a partial region of the axial length thereof and are formed by separate plastic layers. At least one intermediate layer (Z) is embedded in at least a partial region of the body (2) in a space delimited by the outer and inner walls (A, I) of the body (2), the intermediate layer extending across part of the axial length and the circumference of the body (2) and having a color that deviates from the outer or inner layers (A, I).
Patent MX-2009004669-A (MX)
Title: Aqueous film-forming compositions containing reduced levels of volatile organic compounds.
Inventor: JOSHI MAKARAND V
IPC: C08K5/00
Filed: 2007-08-30
Abstract: In addition to acting as effective plasticizers, benzoic acid ester combinations comprising diesters of glycols and at least one of the corresponding monoesters within a specified concentration range are unique in their ability to act as coalescents for aqueous polymer compositions, thereby replacing more volatile organic compounds such as diols, glycols and esters of mono-and dihydric alcohols and benzoates of monohydric alcohols containing 8-10 carbon atoms. Within a preferred concentration range the benzoate combinations impart additional desirable properties to films formed from the polymer composition. These combinations can replace at least a portion of the more volatile organic compounds without any decrease in coalescing ability of the polymers present in the composition.
Patent MX-2009005048-A (MX)
Title: New process for the preparation of 2-imino-thiazolidin-4-one derivatives.
Inventor: BOLLI MARTIN
IPC: C07D277/54
Filed: 2007-11-22
Abstract: The present invention relates to a new process for the preparation of 2-imino- thiazolidin-4-one compounds of the Formula (I) and (II) and to compounds of Formula (II) as such. The present compounds of Formula (II) can be used as intermediates in the preparation of thiazolidin-4-one derivatives of the General Formula (II), said derivatives being described in WO 2005/054215. These compounds of General Formula (II) are described in WO 2005/054215 to act as immunosuppressive agents.
Patent MX-2009005144-A (MX)
Title: Imidazotriazines and imidazopyrimidines as kinase inhibitors.
Inventor: BURNS DAVID M
IPC: C07D487/04
Filed: 2007-11-19
Abstract: The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Patent MX-2009006307-A (MX)
Title: Iron (iii)-carbohydrate based phosphate adsorbent.
Inventor: SEKKAT NABILA
IPC: C01G49/00
Filed: 2007-12-12
Abstract: The present invention relates to a new iron containing phosphate adsorbent and its use e.g. for treating hyperphosphatemia.
Patent MX-2009009710-A (MX)
Title: A method of promoting muscle tissue repair.
Inventor: LIFSHITZ RAN
IPC: A61L31/06
Filed: 2008-03-13
Abstract: A method of treating a muscle tissue which is effected by providing the muscle tissue with an effective amount of a sterile polymer solution being essentially devoid of free multivalent cations and being capable of self-gelling following deposition in or around the muscle tissue.
Patent MX-2009010432-A (MX)
Title: Device for increased eye protection.
Inventor: CARUSO NUNZIO GIUSEPPE
IPC: G02C7/10
Filed: 2008-03-18
Abstract: The invention relates to a device for maximum eye protection, particularly glasses, sun glasses or a pane, comprising filters for influencing and filtering dangerous UV, blue light, and infrared rays, characterized in that the filters filter and influence the transmission of UVC, UVB, UVA, blue light and infrared, wherein the filters have a unique combination for eye protection. The device is also suitable for use in traffic, on ships and for flights. The combination of all of said elements, such as filtration of the UV radiation, blue light and infrared, maximum possible eye protection, and also being suitable for use in traffic, is the core of said invention. Further technologies that are associated with the invention can be added or removed. The automatic brightness settings with and without sensors, polarization filter, energy supply by solar energy, UV, blue light and IR measurements, LCD technologies and mechanical devices in the nose and ear region with bionic technology, that all relieve the eye, can be added.
Patent MX-2009011973-A (MX)
Title: Robust rapid disintegration tablet formulation.
Inventor: DURIG THOMAS
IPC: A61K31/00
Filed: 2008-05-08
Abstract: A rapidly disintegrating, orally administered tablet or compressed dosage form, comprising ethylcellulose (EC) as a directly compressible binder which enhances tablet robustness as manifested by improved strength, lower friability, lower hygroscopicity and yet, hydrophobic nature notwithstanding, does not retard disintegration, but shortens disintegration time or is disintegration time neutral when co-formulated with disintegrants and other water-soluble excipients such as sugar alcohols.
Patent MX-2009014079-A (MX)
Title: Pe molding composition for blow-molding of small low-density blow moldings.
Inventor: BERTHOLD JOACHIM
IPC: C08L23/06
Filed: 2008-06-26
Abstract: The invention relates to a polyethylene molding composition with polymodal molar mass distribution which is particularly suitable for blow molding of small blow moldings whose capacity is in the range from 250 to 5000 ml. The density of the molding composition at a temperature of 23 Â°C is in the range from 0.949 to 0.954 g/cm3, and its MFI190/5 is in the range from 1.3 to 2.0 g/10 min. It comprises from 37 to 43% by weight of a low-molecular-weight ethylene homopolymer A, from 37 to 43% by weight of a high-molecular-weight copolymer B composed of ethylene and of another olefin having from 4 to 8 carbon atoms, and from 18 to 23% by weight of an ultrahigh-molecular-weight ethylene copolymer C.
Patent MX-2010002287-A (MX)
Title: Beverage dispenser.
Inventor: ANTAO LEONARD F
IPC: G07F9/02
Filed: 2008-09-04
Abstract: Embodiments of the invention can include systems and methods for dispensing consumable products. One embodiment of the invention can provide a product dispenser. The product dispenser can include an ingredient matrix operable to receive a plurality of product ingredients. In addition, the product dispenser can include a controller in communication with the ingredient matrix, and operable to execute a set of instructions to receive product data associated with the plurality of product ingredients. Moreover, the controller can further comprise a set of instructions to track usage of the plurality of product ingredients when at least one product is dispensed. Furthermore, the controller can further comprise a set of instructions to update the product data during or after dispensing of a product or installation of one or more product ingredients in the ingredient matrix.
Patent MX-2010002404-A (MX)
Title: Polyunsaturated fatty acid-containing solid fat compositions and uses and production thereof.
Inventor: SENANAYAKE JANAKA NAMAL S P
IPC: A23L33/00
Filed: 2008-08-29
Abstract: The present invention provides a solid fat composition that includes an oil having saturated fat and an oil having at least one long chain polyunsaturated fatty acid. In particular, the solid fat composition can have high levels of long chain polyunsaturated fatty acid and low to no presence of emulsifiers. In preferred embodiments, the polyunsaturated oil is an unwinterized microbial oil. The invention also relates to methods for making such compositions and food, nutritional, and pharmaceutical products comprising said compositions.
Patent MX-2010003606-A (MX)
Title: Antisense modulation of fibroblast growth factor receptor 4 expression.
Inventor: FREIER SUSAN M
IPC: C07H21/04
Filed: 2008-10-01
Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 4. Methods of using these compounds for modulation of fibroblast growth factor receptor 4 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 4 are provided.